Diabetes Care 31 , 18161823 (2008)
Then you may need "maintenance" injections every four weeks
Failure to Adequately Warn Patients About Known Risks The master complaint filed in MDL 3094 alleges that Novo Nordisk and Eli Lilly knew or should have known about the severe gastroparesis and vision loss risks associated with their GLP-1 medications but failed to provide adequate warnings on product labels, marketing materials, or prescribing information
About the Alzheimer's Association International Conference (AAIC ) The Alzheimers Association International Conference (AAIC) is the worlds largest gathering of researchers from around the world focused on Alzheimers and other dementias
In aged mouse models, researchers observed that FOXO4-DRI administration was associated with changes in senescence biomarker levels and functional parameters
Since risks and monitoring needs vary by individual and by GLP-1 drug, you should rely on your clinician for personalized guidance and instructions